Navigation Links
VCA fellowship funding to extend ovarian cancer research
Date:10/26/2010

Dr Clare Scott from the Walter and Eliza Hall Institute in Melbourne, Australia, has been awarded a Victorian Cancer Agency (VCA) Clinical Fellowship to further research into an aggressive and highly lethal form of ovarian cancer.

Epithelial ovarian cancer, which is found in the cell lining (epithelium) of the ovary, accounts for 90 per cent of ovarian tumours. However, epithelial ovarian cancer is still poorly understood, and recent research has revealed that it may start in cells outside of the ovary.

Dr Scott is a laboratory head in the institute's Stem Cells and Cancer and Molecular Genetics of Cancer divisions and a medical oncologist at The Royal Melbourne Hospital. She said the VCA fellowship, worth $400,000 over two years, would help her to search for the origins of ovarian cancer.

"In addition to working out where ovarian cancer starts, we need more precise ways of studying human ovarian cancers in the laboratory and, with the VCA funding, we will work on improving those laboratory models," Dr Scott said.

"Because ovarian cancer becomes resistant to current therapies so often, it is essential that we discover new treatments. Being able to accurately study human ovarian cancers in animal models provides great advantages in this regard."

Dr Scott said the VCA funding would help to further fundamental research in the area, including the development of a more useful pre-clinical model for ovarian cancer than is currently available for testing new drugs.

Each year, more than 1200 Australian women are diagnosed with ovarian cancer, and around 800 will die from the disease. Ovarian cancer is the sixth major cause of cancer deaths in Australian women. Despite efforts to develop better screening tools, 80 per cent of epithelial ovarian cancers are diagnosed after they have spread beyond the ovary and 70 per cent are generally incurable.

Dr Scott is also the principal investigator in a program called CART-WHEEL.org, which receives funding from the Victorian Cancer Agency. CART-WHEEL.org is a web portal dedicated to coordinating patient information, research studies and clinical trials for rare cancers. Dr Scott will use this web portal to study rare ovarian cancers.

"The website provides a new way of linking patients into the system of research and clinical trials," Dr Scott said. "This increases the number of patients available for specialised research, with the ultimate goal of gathering enough entries over time to make clinical trials for different types of rare tumours a possibility."


'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Related medicine news :

1. Fellowship allows diverse reporters to cultivate public awareness of aging issues
2. AWARD Fellowship highlights critical role of African women in agricultural research
3. Kennedy Krieger Institutes Dr. Paul Lipkin selected for national health policy fellowship
4. Outstanding high school students receive AGA Foundation 2010 Student Research Fellowship Awards
5. University of Toronto scholars receive prestigious New Directions Fellowships
6. Fellowship winners make cancer their focus
7. AADR awards the 2010 AADR William B. Clark Fellowship to Isabel Gay
8. UCI stem cell researchers to receive $9.35 million in state funding
9. Hepatitis E research receives funding
10. MJFF announces over $10 million in funding for clinical and pre-clinical PD research
11. UCI gets major funding to study ways of preventing drug-resistant staph infections
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
VCA fellowship funding to extend ovarian cancer research
(Date:3/28/2017)... ... March 29, 2017 , ... The ... Dr. Isabella Wentz, Pharm.D., FASCP. The program was recently launched on March 1, ... questions regarding thyroid function. , Dr. Izabella Wentz is a licensed pharmacist ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... services, is proud to announce it has joined the National Association for Home ... interests of chronically ill, disabled, and dying Americans of all ages and the ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Alert Sentry ... of MPERS (Mobile Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These ... market. The first of their kind, the iSAFE and iSAFE Plus offer direct GPS ...
(Date:3/28/2017)... ... March 28, 2017 , ... Usually, the impending arrival of ... However, for those self-conscious about a double chin, this means more anxiety than elation. ... , “For most people, a double chin is undesirable,” Dr. Goldman said, “but ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... leading physicians, Paul Yost, will begin serving as new board chair for Orange ... month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017 Elysium ... with Cambridge academic ...   The Milner Therapeutics Institute today announces Elysium ... Health has committed significant investment for collaborative projects with academic ... four years. This is the first major research investment outside ...
(Date:3/27/2017)... Summary This report provides all the ... partnering interests and activities since 2010. Description The Partnering ... into the partnering activity of one of the world,s leading ... prepared upon purchase to ensure inclusion of the most up ... will be delivered in PDF format within 1 working day ...
(Date:3/27/2017)...  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, ... and efficacy studies. The company is harnessing the power ... MAGE A, in an effort to find a better ... After 4 weeks of treatment in transgenic mice, the ... in a full toxicology report of various organs. Cytotoxic ...
Breaking Medicine Technology: